Literature DB >> 22013401

Optimization of nonlinear dose- and concentration-response models utilizing evolutionary computation.

Andrew L Beam1, Alison A Motsinger-Reif.   

Abstract

An essential part of toxicity and chemical screening is assessing the concentrated related effects of a test article. Most often this concentration-response is a nonlinear, necessitating sophisticated regression methodologies. The parameters derived from curve fitting are essential in determining a test article's potency (EC(50)) and efficacy (E(max)) and variations in model fit may lead to different conclusions about an article's performance and safety. Previous approaches have leveraged advanced statistical and mathematical techniques to implement nonlinear least squares (NLS) for obtaining the parameters defining such a curve. These approaches, while mathematically rigorous, suffer from initial value sensitivity, computational intensity, and rely on complex and intricate computational and numerical techniques. However if there is a known mathematical model that can reliably predict the data, then nonlinear regression may be equally viewed as parameter optimization. In this context, one may utilize proven techniques from machine learning, such as evolutionary algorithms, which are robust, powerful, and require far less computational framework to optimize the defining parameters. In the current study we present a new method that uses such techniques, Evolutionary Algorithm Dose Response Modeling (EADRM), and demonstrate its effectiveness compared to more conventional methods on both real and simulated data.

Entities:  

Keywords:  Evolutionary Algorithm; Hill-Slope Model; Nonlinear Regression; Parameter Estimation

Year:  2010        PMID: 22013401      PMCID: PMC3186933          DOI: 10.2203/dose-response.09-030.Beam

Source DB:  PubMed          Journal:  Dose Response        ISSN: 1559-3258            Impact factor:   2.658


  7 in total

1.  Alternative Cross-Over Strategies and Selection Techniques for Grammatical Evolution Optimized Neural Networks.

Authors:  Alison A Motsinger; Lance W Hahn; Scott M Dudek; Kelli K Ryckman; Marylyn D Ritchie
Journal:  Genet Evol Comput Conf       Date:  2006

2.  Prediction of cytotoxicity data (CC(50)) of anti-HIV 5-phenyl-1-phenylamino-1H-imidazole derivatives by artificial neural network trained with Levenberg-Marquardt algorithm.

Authors:  M Arab Chamjangali; M Beglari; G Bagherian
Journal:  J Mol Graph Model       Date:  2007-01-18       Impact factor: 2.518

3.  A comparison of analytical methods for genetic association studies.

Authors:  Alison A Motsinger-Reif; David M Reif; Theresa J Fanelli; Marylyn D Ritchie
Journal:  Genet Epidemiol       Date:  2008-12       Impact factor: 2.135

4.  Comparison of immortalized Fa2N-4 cells and human hepatocytes as in vitro models for cytochrome P450 induction.

Authors:  Niresh Hariparsad; Brian A Carr; Raymond Evers; Xiaoyan Chu
Journal:  Drug Metab Dispos       Date:  2008-03-10       Impact factor: 3.922

5.  Quantitative nuclease protection assay in paraffin-embedded tissue replicates prognostic microarray gene expression in diffuse large-B-cell lymphoma.

Authors:  Robin A Roberts; Constantine M Sabalos; Michael L LeBlanc; Ralph R Martel; Yvette M Frutiger; Joseph M Unger; Ihab W Botros; Matthew P Rounseville; Bruce E Seligmann; Thomas P Miller; Thomas M Grogan; Lisa M Rimsza
Journal:  Lab Invest       Date:  2007-08-13       Impact factor: 5.662

6.  Dioxin-responsive genes: examination of dose-response relationships using quantitative reverse transcriptase-polymerase chain reaction.

Authors:  J P Vanden Heuvel; G C Clark; M C Kohn; A M Tritscher; W F Greenlee; G W Lucier; D A Bell
Journal:  Cancer Res       Date:  1994-01-01       Impact factor: 12.701

7.  Neural networks for genetic epidemiology: past, present, and future.

Authors:  Marylyn D Ritchie; Alison A Motsinger-Reif
Journal:  BioData Min       Date:  2008-07-17       Impact factor: 2.522

  7 in total
  8 in total

1.  Evaluation of statistical approaches for association testing in noisy drug screening data.

Authors:  Petr Smirnov; Ian Smith; Zhaleh Safikhani; Wail Ba-Alawi; Farnoosh Khodakarami; Eva Lin; Yihong Yu; Scott Martin; Janosch Ortmann; Tero Aittokallio; Marc Hafner; Benjamin Haibe-Kains
Journal:  BMC Bioinformatics       Date:  2022-05-18       Impact factor: 3.307

2.  Contextualizing Hepatocyte Functionality of Cryopreserved HepaRG Cell Cultures.

Authors:  Jonathan P Jackson; Linhou Li; Erica D Chamberlain; Hongbing Wang; Stephen S Ferguson
Journal:  Drug Metab Dispos       Date:  2016-06-23       Impact factor: 3.922

3.  Current Methods for Quantifying Drug Synergism.

Authors:  Jun Ma; Alison Motsinger-Reif
Journal:  Proteom Bioinform       Date:  2019-07-22

4.  A comparison of association methods for cytotoxicity mapping in pharmacogenomics.

Authors:  Chad Brown; Tammy M Havener; Lorraine Everitt; Howard McLeod; Alison A Motsinger-Reif
Journal:  Front Genet       Date:  2011-12-14       Impact factor: 4.599

5.  Beyond IC50s: Towards Robust Statistical Methods for in vitro Association Studies.

Authors:  Andrew Beam; Alison Motsinger-Reif
Journal:  J Pharmacogenomics Pharmacoproteomics       Date:  2014-03-01

Review 6.  An Introduction to Terminology and Methodology of Chemical Synergy-Perspectives from Across Disciplines.

Authors:  Kyle R Roell; David M Reif; Alison A Motsinger-Reif
Journal:  Front Pharmacol       Date:  2017-04-20       Impact factor: 5.810

7.  A Universal Delayed Difference Model Fitting Dose-response Curves.

Authors:  Linqian Yang; Jiaying Wang; Robert A Cheke; Sanyi Tang
Journal:  Dose Response       Date:  2021-12-15       Impact factor: 2.658

8.  Nonlinear Dose-Response Modeling of High-Throughput Screening Data Using an Evolutionary Algorithm.

Authors:  Jun Ma; Eric Bair; Alison Motsinger-Reif
Journal:  Dose Response       Date:  2020-05-22       Impact factor: 2.658

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.